lobbying_filings_raw: 751ebd2d-e086-4c61-8bff-ca32dd4edd63
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 751ebd2d-e086-4c61-8bff-ca32dd4edd63 | Q4 | 400577737 | THE INGRAM GROUP LLC | 193009 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | fourth_quarter | 2013-01-19T22:13:20.820000-05:00 | 60000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/751ebd2d-e086-4c61-8bff-ca32dd4edd63/", "filing_uuid": "751ebd2d-e086-4c61-8bff-ca32dd4edd63", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2012, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/751ebd2d-e086-4c61-8bff-ca32dd4edd63/print/", "filing_document_content_type": "text/html", "income": "60000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Robert A. Russell, Partner", "dt_posted": "2013-01-19T22:13:20.820000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": "601 Pennsylvania Avenue", "registrant_address_2": "Suite 210", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 400577737, "url": "https://lda.senate.gov/api/v1/registrants/400577737/", "house_registrant_id": null, "name": "THE INGRAM GROUP LLC", "description": "strategic affairs firm", "address_1": "875 15th Street, NW Ste 600", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "AMANDA BUNNING KELSEY", "contact_telephone": "+1 202-683-6833", "dt_updated": "2026-01-23T16:26:29.709092-05:00"}, "client": {"id": 193009, "url": "https://lda.senate.gov/api/v1/clients/193009/", "client_id": 125, "name": "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", "general_description": "trade group representing U.S. pharmaceutical research and biotechnology companies", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2011-02-22"}, "lobbying_activities": [{"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Issues related to the Patent Reform Act of 2011, S.23.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51371, "prefix": null, "prefix_display": null, "first_name": "BERNARD", "nickname": null, "middle_name": null, "last_name": "TOON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 51395, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": "A", "last_name": "RUSSELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53557, "prefix": null, "prefix_display": null, "first_name": "KYLE", "nickname": null, "middle_name": null, "last_name": "SIMMONS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to the implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012, Public Law No: 112-144.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51371, "prefix": null, "prefix_display": null, "first_name": "BERNARD", "nickname": null, "middle_name": null, "last_name": "TOON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 51395, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": "A", "last_name": "RUSSELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53557, "prefix": null, "prefix_display": null, "first_name": "KYLE", "nickname": null, "middle_name": null, "last_name": "SIMMONS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to the Patient Protection and Affordable Care Act, P.L. 111-148: Medicare issues related to the Independent Payment Advisory Board (IPAB), Medicare funding issues, P.L. 112-25, the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012, H.R. 8.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51371, "prefix": null, "prefix_display": null, "first_name": "BERNARD", "nickname": null, "middle_name": null, "last_name": "TOON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 51395, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": "A", "last_name": "RUSSELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53557, "prefix": null, "prefix_display": null, "first_name": "KYLE", "nickname": null, "middle_name": null, "last_name": "SIMMONS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Issues related to pharmaceutical importation, generic drug pricing and the FAIR Generics Act, S.1882.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51371, "prefix": null, "prefix_display": null, "first_name": "BERNARD", "nickname": null, "middle_name": null, "last_name": "TOON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 51395, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": "A", "last_name": "RUSSELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 53557, "prefix": null, "prefix_display": null, "first_name": "KYLE", "nickname": null, "middle_name": null, "last_name": "SIMMONS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |